{"transactions":[{"id":1327425,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-18T23:18:48.000Z","date":"2024-12-17","kind":"sale","planned":true,"acquired":false,"shares":547,"price":22.04,"value":12055.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Partial disposition of RSUs to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":124167,"source":{"system":"sec-edgar","filing":"0001628280-24-051924","document":"wk-form4_1734563922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828024051924/wk-form4_1734563922.xml","form_type":"4"}},{"id":1327424,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-18T23:18:48.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":21.9,"value":109500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $21.64 to $22.20, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Partial disposition of RSUs to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":124714,"source":{"system":"sec-edgar","filing":"0001628280-24-051924","document":"wk-form4_1734563922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828024051924/wk-form4_1734563922.xml","form_type":"4"}},{"id":1679426,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-16T23:06:55.000Z","date":"2024-01-11","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":38.55,"value":42405.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $38.15 to $39.21, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Partial disposition of RSUs to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":129711,"source":{"system":"sec-edgar","filing":"0001628280-24-001425","document":"wk-form4_1705446400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828024001425/wk-form4_1705446400.xml","form_type":"4"}},{"id":1679425,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-16T23:06:55.000Z","date":"2024-01-11","kind":"sale","planned":true,"acquired":false,"shares":1811,"price":37.76,"value":68383.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $38.13, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Partial disposition of RSUs to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":130811,"source":{"system":"sec-edgar","filing":"0001628280-24-001425","document":"wk-form4_1705446400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828024001425/wk-form4_1705446400.xml","form_type":"4"}},{"id":1705872,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T20:51:34.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":14987,"price":25.41,"value":380819.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units, which will vest in one installment on the first anniversary date."}],"balance_after":132622,"source":{"system":"sec-edgar","filing":"0001628280-23-041962","document":"wk-form4_1703019085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828023041962/wk-form4_1703019085.xml","form_type":"4"}},{"id":1901509,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-08T22:29:07.000Z","date":"2023-05-05","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":40.9,"value":265850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $40.59 to $41.22, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the reporting person which are subject to certain vesting conditions."}],"balance_after":117635,"source":{"system":"sec-edgar","filing":"0001628280-23-016560","document":"wf-form4_168358492995664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828023016560/wf-form4_168358492995664.xml","form_type":"4"}},{"id":1984986,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-01T23:14:49.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":875,"price":32.62,"value":28542.5,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Anne Given Trust (\"AG Trust\"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-23-014275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919123014275/doc4.xml","form_type":"4"}},{"id":2056910,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T01:27:55.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":4593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options, which will vest in one installment on the first anniversary of the grant date."}],"balance_after":4593,"derivative":{"exercise_price":33.03,"exercise_date":"2024-01-10","expiration_date":"2033-01-10","underlying":"Common Stock","underlying_shares":4593},"source":{"system":"sec-edgar","filing":"0001209191-23-003075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919123003075/doc4.xml","form_type":"4"}},{"id":2056909,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T01:27:55.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":7867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":124135,"source":{"system":"sec-edgar","filing":"0001209191-23-003075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919123003075/doc4.xml","form_type":"4"}},{"id":2440702,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-08T01:10:07.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":116268,"source":{"system":"sec-edgar","filing":"0001209191-22-002590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122002590/doc4.xml","form_type":"4"}},{"id":2457461,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-30T01:44:11.000Z","date":"2021-12-28","kind":"purchase","acquired":true,"shares":655,"price":66.37,"value":43472.35,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":109868,"source":{"system":"sec-edgar","filing":"0001209191-21-071563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121071563/doc4.xml","form_type":"4"}},{"id":2457460,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-30T01:44:11.000Z","date":"2021-12-28","kind":"gift","acquired":false,"shares":655,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":109213,"source":{"system":"sec-edgar","filing":"0001209191-21-071563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121071563/doc4.xml","form_type":"4"}},{"id":2573974,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-10T20:53:36.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":5000,"price":65.24,"value":326200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.20 to $65.33, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":109868,"source":{"system":"sec-edgar","filing":"0001209191-21-055474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121055474/doc4.xml","form_type":"4"}},{"id":2656498,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T20:47:24.000Z","date":"2021-06-22","kind":"sale","acquired":false,"shares":4500,"price":89.21,"value":401445.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.90 to $89.38, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":114868,"source":{"system":"sec-edgar","filing":"0001209191-21-043051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121043051/doc4.xml","form_type":"4"}},{"id":2837110,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-24T23:51:33.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":1125,"price":88.73,"value":99821.25,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities owned directly by Anne Given Trust (\"AG Trust\"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust."}],"balance_after":13875,"source":{"system":"sec-edgar","filing":"0001209191-21-013974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121013974/doc4.xml","form_type":"4"}},{"id":2905101,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-19T22:58:41.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":3000,"price":83.28,"value":249840.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.98 to $83.40, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities owned directly by Katherine Given Ligtenberg Trust (\"KGL Trust\"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-21-004076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121004076/doc4.xml","form_type":"4"}},{"id":2923322,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T23:11:24.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":4000,"price":76.08,"value":304320.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.86 to $76.26, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":119368,"source":{"system":"sec-edgar","filing":"0001209191-21-001527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121001527/doc4.xml","form_type":"4"}},{"id":2923321,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T23:11:24.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":123368,"source":{"system":"sec-edgar","filing":"0001209191-21-001527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121001527/doc4.xml","form_type":"4"}},{"id":2930522,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-22","kind":"gift","acquired":false,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":113868,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930521,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-21","kind":"gift","acquired":false,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":113903,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930520,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-21","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":113938,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930519,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-17","kind":"gift","acquired":false,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114138,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930518,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-17","kind":"gift","acquired":false,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114173,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930517,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-17","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114208,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930516,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-17","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114408,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930515,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-17","kind":"gift","acquired":false,"shares":65,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114608,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2930514,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-29T22:55:47.000Z","date":"2020-12-17","kind":"gift","acquired":false,"shares":65,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114673,"source":{"system":"sec-edgar","filing":"0001209191-20-065396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120065396/doc4.xml","form_type":"4"}},{"id":2938608,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T23:26:35.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":500,"price":79.59,"value":39795.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.57 to $79.63, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities owned directly by Anne Given Trust (\"AG Trust\"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-20-064497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120064497/doc4.xml","form_type":"4"}},{"id":2938607,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T23:26:35.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":9075,"price":79.3,"value":719647.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.75 to $79.65, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":114738,"source":{"system":"sec-edgar","filing":"0001209191-20-064497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120064497/doc4.xml","form_type":"4"}},{"id":2938606,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T23:26:35.000Z","date":"2020-12-07","kind":"gift","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities owned directly by Katherine Given Ligtenberg Trust (\"KGL Trust\"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust."}],"balance_after":15500,"source":{"system":"sec-edgar","filing":"0001209191-20-064497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120064497/doc4.xml","form_type":"4"}},{"id":2938605,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T23:26:35.000Z","date":"2020-12-07","kind":"gift","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities owned directly by Anne Given Trust (\"AG Trust\"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust."}],"balance_after":15500,"source":{"system":"sec-edgar","filing":"0001209191-20-064497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120064497/doc4.xml","form_type":"4"}},{"id":2938604,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T23:26:35.000Z","date":"2020-12-07","kind":"gift","acquired":false,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":123813,"source":{"system":"sec-edgar","filing":"0001209191-20-064497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120064497/doc4.xml","form_type":"4"}},{"id":3176001,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-16T23:47:11.000Z","date":"2020-04-14","kind":"gift","acquired":false,"shares":1112,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":154813,"source":{"system":"sec-edgar","filing":"0001209191-20-024687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120024687/doc4.xml","form_type":"4"}},{"id":3176000,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-16T23:47:11.000Z","date":"2020-04-14","kind":"sale","acquired":false,"shares":25000,"price":36.89,"value":922250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.63 to\n$37.22, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":155925,"source":{"system":"sec-edgar","filing":"0001209191-20-024687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120024687/doc4.xml","form_type":"4"}},{"id":3325047,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T22:54:31.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":180925,"source":{"system":"sec-edgar","filing":"0001209191-20-001333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120001333/doc4.xml","form_type":"4"}},{"id":3633938,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options fully vested on the 1 year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":4.75,"exercise_date":"2014-09-21","expiration_date":"2023-09-21","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633937,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options fully vested on the 1 year anniversary of the grant date."}],"balance_after":7000,"derivative":{"exercise_price":2.62,"exercise_date":"2013-09-28","expiration_date":"2022-09-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633936,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options fully vested on the 1 year anniversary of the grant date."}],"balance_after":17000,"derivative":{"exercise_price":2.19,"exercise_date":"2014-03-21","expiration_date":"2023-03-21","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633935,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options fully vested on the 1 year anniversary of the grant date."}],"balance_after":35000,"derivative":{"exercise_price":5.19,"exercise_date":"2013-02-16","expiration_date":"2022-02-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633934,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":65000,"price":19.25,"value":1251250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $19.30, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":175130,"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633933,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":7000,"price":4.75,"value":33250.0,"ownership":{"direct":true},"balance_after":240130,"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633932,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":10000,"price":2.62,"value":26200.0,"ownership":{"direct":true},"balance_after":233130,"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633931,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":18000,"price":2.19,"value":39420.0,"ownership":{"direct":true},"balance_after":223130,"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633930,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":30000,"price":5.19,"value":155700.0,"ownership":{"direct":true},"balance_after":205130,"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3633929,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T00:32:14.000Z","date":"2019-02-22","kind":"sale","acquired":false,"shares":3000,"price":18.05,"value":54150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.92 to $18.18, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":175130,"source":{"system":"sec-edgar","filing":"0001209191-19-013821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119013821/doc4.xml","form_type":"4"}},{"id":3688658,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-25T01:46:05.000Z","date":"2019-01-22","kind":"sale","acquired":false,"shares":3000,"price":13.58,"value":40740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.32 to $14.30, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":178130,"source":{"system":"sec-edgar","filing":"0001209191-19-005259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119005259/doc4.xml","form_type":"4"}},{"id":3710963,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T01:13:40.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":181130,"source":{"system":"sec-edgar","filing":"0001209191-19-001537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119001537/doc4.xml","form_type":"4"}},{"id":3717101,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T22:20:56.000Z","date":"2018-12-27","kind":"sale","acquired":false,"shares":3000,"price":12,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":145130,"source":{"system":"sec-edgar","filing":"0001209191-18-064340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118064340/doc4.xml","form_type":"4"}},{"id":3753294,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-27T02:09:58.000Z","date":"2018-11-23","kind":"sale","acquired":false,"shares":3000,"price":12.74,"value":38220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.58 to $12.76, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":148130,"source":{"system":"sec-edgar","filing":"0001209191-18-059974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118059974/doc4.xml","form_type":"4"}},{"id":3785578,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-24T00:06:33.000Z","date":"2018-10-22","kind":"gift","acquired":false,"shares":3870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":151130,"source":{"system":"sec-edgar","filing":"0001209191-18-056001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118056001/doc4.xml","form_type":"4"}},{"id":3957528,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-25T23:40:05.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":25000,"price":6.63,"value":165750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.48 to $6.89, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":155000,"source":{"system":"sec-edgar","filing":"0001209191-18-026146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118026146/doc4.xml","form_type":"4"}},{"id":4114702,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T00:39:04.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":180000,"source":{"system":"sec-edgar","filing":"0001209191-18-001530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118001530/doc4.xml","form_type":"4"}},{"id":4504998,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T01:48:54.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-17-001619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919117001619/doc4.xml","form_type":"4"}},{"id":4578626,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-18T23:53:25.000Z","date":"2016-10-14","kind":"sale","acquired":false,"shares":12000,"price":6.72,"value":80640.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001209191-16-146247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919116146247/doc4.xml","form_type":"4"}},{"id":4578625,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":84953,"kind":"person","name":"GIVEN DOUGLAS B","position":1,"cik":"0001156207","reported_name":"GIVEN DOUGLAS B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-18T23:53:25.000Z","date":"2016-01-12","kind":"gift","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions."}],"balance_after":82000,"source":{"system":"sec-edgar","filing":"0001209191-16-146247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919116146247/doc4.xml","form_type":"4"}}]}